Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

EMBC

Embecta Corp

Dec 13 • 04:00PM ET

19.51

Dollar change -0.17
Percentage change -0.86	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR IWM VTI VB VBR VXF IJS SPSM IWN FNDA

Scroll to Statements

Index	RUT	P/E	14.41	EPS (ttm)	1.35	Insider Own	7.44%	Shs Outstand	57.71M	Perf Week	1.40%
Market Cap	1.12B	Forward P/E	6.44	EPS next Y	3.03	Insider Trans	0.00%	Shs Float	53.41M	Perf Month	26.69%
Income	78.30M	PEG	2.21	EPS next Q	0.44	Inst Own	90.76%	Short Float	2.28%	Perf Quarter	18.46%
Sales	1.12B	P/S	1.00	EPS this Y	14.49%	Inst Trans	-1.06%	Short Ratio	3.12	Perf Half Y	52.42%
Book/sh	-12.79	P/B	-	EPS next Y	7.96%	ROA	6.26%	Short Interest	1.22M	Perf Year	8.93%
Cash/sh	4.76	P/C	4.10	EPS next 5Y	6.51%	ROE	-	52W Range	9.93 - 21.48	Perf YTD	3.06%
Dividend Est.	0.60 (3.07%)	P/FCF	56.50	EPS past 5Y	-	ROI	9.01%	52W High	-9.17%	Beta	1.20
Dividend TTM	0.60 (3.08%)	Quick Ratio	1.58	Sales past 5Y	0.32%	Gross Margin	64.94%	52W Low	96.57%	ATR (14)	1.02
Dividend Ex-Date	Dec 06, 2024	Current Ratio	2.03	EPS Y/Y TTM	10.44%	Oper. Margin	25.12%	RSI (14)	62.54	Volatility	3.73% 6.01%
Employees	2100	Debt/Eq	-	Sales Y/Y TTM	0.21%	Profit Margin	6.97%	Recom	2.75	Target Price	22.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	140.61%	Payout	44.70%	Rel Volume	0.63	Prev Close	19.68
Sales Surprise	3.30%	EPS Surprise	24.31%	Sales Q/Q	1.49%	Earnings	Nov 26 BMO	Avg Volume	390.79K	Price	19.51
SMA20	8.98%	SMA50	24.39%	SMA200	39.96%	Trades		Volume	246,509	Change	-0.86%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
01:15PM	Loading…
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	Loading…
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
07:47AM	Loading…
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47% -7.91%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)
Jan-24-24 05:00PM	embecta to Report Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
Jan-21-24 08:33AM	16 Most Profitable New Stocks Today (Insider Monkey)
Jan-09-24 06:00AM	embecta Announces FDA 510(k) Submission for Insulin Patch Pump (GlobeNewswire)
Dec-14-23 05:00PM	embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-01-23 06:00AM	No embecta-made syringes impacted by FDA safety communication (GlobeNewswire)
05:13AM	Embecta Corp's Dividend Analysis (GuruFocus.com)
Nov-29-23 05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
Nov-22-23 09:34AM	Embecta Corp. (NASDAQ:EMBC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-21-23 07:23AM	Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s (MedTech Dive)
07:15AM	Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Embecta Corp (EMBC) Posts Mixed Fiscal 2023 Results and Issues Fiscal 2024 Guidance (GuruFocus.com)
05:30AM	Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance (GlobeNewswire)
05:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-14-23 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline (Zacks) +7.29%
Oct-31-23 06:50AM	embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell (GlobeNewswire)
Oct-25-23 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) -9.02%
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-06-23 05:00PM	embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference (GlobeNewswire) -13.20%
Aug-11-23 06:08AM	Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15 (Simply Wall St.)
Aug-08-23 10:19PM	Q3 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-11-23 05:00PM	embecta to Report Fiscal Third Quarter 2023 Financial Results (GlobeNewswire)
Jun-30-23 06:15AM	The Market Doesn't Like What It Sees From Embecta Corp.'s (NASDAQ:EMBC) Revenues Yet (Simply Wall St.)
Jun-21-23 08:00PM	EMBC: Lowering target price to $26.00 (Argus Research)
May-20-23 08:26AM	Just Four Days Till Embecta Corp. (NASDAQ:EMBC) Will Be Trading Ex-Dividend (Simply Wall St.)
May-15-23 05:38PM	UPDATE -- embecta to Participate in Investor Conferences (GlobeNewswire) -6.45%
05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
09:30AM	Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
May-13-23 08:16AM	Embecta Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
12:05AM	Q2 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
May-12-23 06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire) +6.12%
06:15AM	embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-23 01:08PM	Embecta (EMBC) to Report Q2 Earnings: What's in Store? (Zacks)
Apr-26-23 08:00PM	EMBC: Lowering target price to $29.00 (Argus Research)
Apr-22-23 07:20AM	3 Top Dividend Kings to Buy for the Long Haul (Motley Fool)
Apr-21-23 06:15PM	Embecta Corp. (EMBC) Outpaces Stock Market Gains: What You Should Know (Zacks)
Apr-20-23 05:00PM	embecta to Report Fiscal Second Quarter 2023 Financial Results (GlobeNewswire)
Mar-26-23 08:45AM	3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential (Motley Fool)
Mar-22-23 06:46AM	Investors in Embecta (NASDAQ:EMBC) from a year ago are still down 25%, even after 3.5% gain this past week (Simply Wall St.) -5.70%
Mar-10-23 10:32AM	3 Medical Services Stocks to Buy Amid Industry Challenges (Zacks)
Feb-24-23 10:00AM	Best Momentum Stocks to Buy for February 24th (Zacks)
05:50AM	Best Value Stocks to Buy for February 24th (Zacks)
Feb-22-23 05:00PM	embecta sponsors educational symposium at ATTD 2023 (GlobeNewswire)
Feb-16-23 07:28AM	Daily Vickers Top Buyers & Sellers for 02/16/2023 (Argus Research) -5.28%
Feb-15-23 04:53PM	Embecta Corp. (NASDAQ:EMBC) Q1 2023 Earnings Call Transcript (Insider Monkey)
05:32AM	Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 45% Above Its Share Price (Simply Wall St.)
Feb-14-23 06:54PM	Why Embecta Stock Popped by Nearly 13% Today (Motley Fool) +12.56%

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	Feb 12 '24	Buy	16.25	2,000	32,500	45,080	Feb 12 07:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your FINVIZ experience